Alzheimer’s disease (AD), accounting for 60–80% of dementia diagnoses, is marked by progressive memory loss, deficits in other cognitive domains, deposition of beta-amyloid (Aβ) and hyperphosphorylated tau, and behavioral disturbances. The gene discussed is MAPT; the disease is Alzheimer disease.